US › Healthcare

Assembly Biosciences Inc (ASMB)

US · Healthcare · Biotechnology

$26.44+4.26%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$8.2M
Revenue YoY
-12.8%
Net profit
$-9.1M
Profit YoY
-3.0%
EPS
$-0.54
EPS estimate
$-0.64
Net margin
-110.5%

EPS came in at -0.54 against a street estimate of -0.64 — a beat of 15.6%.

Key statistics

Market cap
$502.6M
P/E
317.0
Forward P/E
14.3
P/B
2.51
Book value
$12.50
EPS (TTM)
$0.08
52-week high
$39.71
52-week low
$18.50
50-day MA
$25.85
200-day MA
$29.24
Beta
1.09

Analyst view

Analysts rate Assembly Biosciences Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $50.00.

Shareholding

Insiders
28.42%
Institutions
48.57%

Largest institutional holders

FundStake
Farallon Capital Management, L.L.C.6.19%
RA Capital Management, LLC5.15%
COMMODORE CAPITAL LP5.05%
HHG PLC4.29%
Paradigm Biocapital Advisors LP3.36%
Vanguard Group Inc2.89%
Vanguard Capital Management, LLC2.47%
Parkman Healthcare Partners LLC2.08%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Assembly Biosciences Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.